Trauma-Focused Intervention With Women Experiencing Homelessness

Sponsor
Rush University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05873517
Collaborator
National Center for Advancing Translational Sciences (NCATS) (NIH), National Institutes of Health (NIH) (NIH)
50
2
2
16.7
25
1.5

Study Details

Study Description

Brief Summary

Homelessness and associated traumas disproportionately affect women. The biopsychosocial health consequences of untreated trauma are profound. PTSD frequently co-occurs with other chronic health conditions, including substance use disorders (SUD). Co-morbid PTSD and SUD (PTSD+SUD) is common and difficult to treat, resulting in severe morbidity and premature mortality among women experiencing homelessness. Executing this study will help to address the disproportionate PTSD+SUD comorbidity burden, which drives health inequities in the growing population of women experiencing homelessness within and beyond Chicago.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Immediate Narrative Exposure Therapy (NET)+
  • Behavioral: Waitlist + NET+
N/A

Detailed Description

Homelessness and associated traumas disproportionately affect women. The biopsychosocial health consequences of untreated trauma are profound. PTSD frequently co-occurs with other chronic health conditions, including substance use disorders (SUD). Co-morbid PTSD and SUD (PTSD+SUD) is common and difficult to treat, resulting in severe morbidity and premature mortality among women experiencing homelessness. We have systematically adapted a trauma-focused intervention protocol (Narrative Exposure Therapy [NET]) to the self-identified needs and preferences of trauma-affected women experiencing homelessness. This adapted intervention, "NET+", incorporates strengths and preferences identified by women themselves, embedding principles of cognitive behavioral therapy (CBT) into conventional NET. NET+ aims to both employ core NET principles to re-process past trauma in parallel with building present-centered skills to address avoidant coping motives in PTSD+SUD. Via a pragmatic, waitlist randomized controlled trial, we will further assess the feasibility, acceptability, and preliminary effects of a 3-week NET+ intervention protocol with up to 100 women experiencing homelessness. We will determine pre- and post-NET+ intervention PTSD and trauma-related symptom scores (depression, anxiety, somatization, sleep), substance use behaviors, and effect sizes. Executing this study will help to address the disproportionate PTSD+SUD comorbidity burden, which drives health inequities in the growing population of women experiencing homelessness within and beyond Chicago.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Eligible participants will either receive immediate NET+ or be assigned to a waitlist; all participants will be offered the opportunity to enroll in the NET+ intervention.Eligible participants will either receive immediate NET+ or be assigned to a waitlist; all participants will be offered the opportunity to enroll in the NET+ intervention.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Pragmatic, Waitlist Randomized Controlled Trial of a Trauma-Focused Intervention With Women Experiencing Homelessness
Actual Study Start Date :
Apr 12, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate NET+

Receives NET+ immediately

Behavioral: Immediate Narrative Exposure Therapy (NET)+
The basis of this intervention is adapted Narrative Exposure Therapy (NET)+. All participants receive 4-8 active NET+ sessions, including a psychoeducational session.

Active Comparator: Waitlist NET+

Receives NET+ after waitlist

Behavioral: Waitlist + NET+
Waitlist control group participants receive 1 psychoeducational sessions and will be added to a waitlist; waitlist control group participants randomly selected from the waitlist be offered the opportunity to receive the active intervention (NET+).

Outcome Measures

Primary Outcome Measures

  1. Post-Traumatic Stress Disorder Symptoms [6 weeks]

    PTSD Checklist for DSM-5 (PCL-5), range 0-80, higher scores = worse outcome

Secondary Outcome Measures

  1. Depression [6 weeks]

    Patient Health Questionnaire-9, range 0-27, higher scores = worse outcome

  2. Anxiety [6 weeks]

    Generalized Anxiety Disorder 7-item (GAD-7), range 0-27, higher scores = worse outcome

  3. Sleep Problems [6 weeks]

    Insomnia Severity Index (ISI), range 0-28, higher scores = worse outcome

  4. Substance Use [6 weeks]

    Tobacco, Alcohol, Prescription substance use behaviors, medication, and other Substance use Tool (positive/negative screen - positive screen = using substances/worse outcomes)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. self-identifies as a woman;

  2. greater than or equal to 18 years;

  3. positive screen on TAPS-1 (reflecting problematic substance use);

  4. recently (within 1 year) or currently homeless (HRSA definition);

  5. affected by a traumatic life event and trauma-related distress (+Life Events Checklist for DSM-5 Standard [LEC-5] response ≥1 and PTSD Checklist for DSM-5 [PCL-5] score ≥28).

Exclusion Criteria:

(1) impaired decisional capacity to consent to participation (University of California, San Diego Brief Assessment of Capacity to Consent [UBACC] score ≤14.5)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Deborah's Place Chicago Illinois United States 60612
2 Sarah's Circle Chicago Illinois United States 60640

Sponsors and Collaborators

  • Rush University Medical Center
  • National Center for Advancing Translational Sciences (NCATS)
  • National Institutes of Health (NIH)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kirsten A. Dickins, Assistant Professor, Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT05873517
Other Study ID Numbers:
  • 22060903-IRB01
First Posted:
May 24, 2023
Last Update Posted:
May 24, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kirsten A. Dickins, Assistant Professor, Rush University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 24, 2023